Mood Stabilizers News and Research

RSS

Study suggests Risperidone long-acting injection combined with standard treatment helped delay time to relapse in patients with bipolar disorder

Patients with frequently relapsing bipolar disorder had a significant delay in the time to an initial relapse when risperidone long-acting injection (RLAI) was combined with standard treatment, according to a new study. The study compared patients who received RLAI and standard treatment to those who received standard treatment combined with placebo.

4 Feb 2008

Dramatic rise of bipolar disorder in young Americans

According to a new study there has been a dramatic rise in the number of young Americans diagnosed with bipolar disorder in recent years.

4 Sep 2007

Bipolar disorder a growing health issue

The estimated number of youth with office visits with a diagnosis of bipolar disorder substantially increased between 1994 and 2003, while adult visits with a bipolar disorder diagnoses appeared to almost double, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Sep 2007

Urgent need for better understanding of bipolar disease in children and adolescents

The number of visits to a doctor's office that resulted in a diagnosis of bipolar disorder in children and adolescents has increased by 40 times over the last decade, reported researchers funded in part by the National Institutes of Health (NIH).

4 Sep 2007

Modafinil under study for bipolar disorder

A preliminary study of 85 patients with bipolar disorder shows that a drug used to treat patients with sleep disorders might also control the depressive symptoms associated with bipolar disorder.

3 Aug 2007

Childhood-onset bipolar disorder is more common than believed

In bipolar disorder, also called manic-depressive disorder, a person experiences mood changes that fluctuate between periods of abnormally high energy and extreme depression.

2 May 2007

Difficult to distinguish bipolar symptoms in children

At least one-third of the time, the symptoms of bipolar disorder first appear in childhood or adolescence.

26 Apr 2007

Effectiveness of psychosocial treatments for bipolar disorder

This is a follow up study to one released last Thursday in the New England Journal of Medicine on the effects of antidepressants in the treatment of bipolar disorder. Both studies, called STEP-BD, were funded by the National Institute of Mental Health.

4 Apr 2007

Treatment options for bipolar disorder

For depressed people with bipolar disorder who are taking a mood stabilizer, adding an antidepressant medication is no more effective than a placebo (sugar pill), according to results published online on March 28, 2007 in the New England Journal of Medicine.

1 Apr 2007

Anger syndrome not just bouts of bad behaviour

Researchers in the United States are saying that Intermittent Explosive Disorder (IED) often known as Road Rage, may be far more common than previously thought.

6 Jun 2006

Novel approach to treatment of depression and anxiety

A group of investigators of the University of Bologna (Giovanni Fava, Chiara Ruini and Chiara Rafanelli) have published an article on a novel approach to treatment of depression and anxiety in the November issue of the Journal of Clinical Psychiatry.

7 Dec 2005

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

Atypical antipsychotic drugs seem to confer a small increased risk for death when used in people with dementia, concludes a team of researchers from the Keck School of Medicine of the University of Southern California in a meta-analysis of 15 clinical trials published in the October 19 issue of the JAMA: The Journal of the American Medical Association.

18 Oct 2005

Interpersonal and social rhythm therapy is helpful to many people with bipolar disorder

A treatment program that stresses maintaining a regular schedule of daily activities and stability in personal relationships is an effective therapy for bipolar disorder, report University of Pittsburgh School of Medicine researchers in September's Archives of General Psychiatry.

12 Sep 2005

Janssen Pharmaceutica has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®

Janssen Pharmaceutica, the maker of RISPERDAL® (risperidone), the most frequently prescribed antipsychotic medication in the U.S., has sent a letter to health care providers to clarify the risks involved with the use of RISPERDAL®.

26 Jul 2004